FDA Faces Big Questions As It Takes A Closer Look At AI Regulations

An motion system shared by the Food and drug administration before this year showed how the regulator is imagining about potential rules for AI and equipment discovering in health care. But the agency even now has a number of large queries to tackle as it prepares to roll out new steerage.